REVIEW ARTICLE

Volume 10,Issue 3

All Issues
Submit to JMDS
Cite this article
56
Citations
399
Views
29 December 2016

Japanese initiative for education in pharmaceutical medicine and clinical research training

Akiko Kishi1 ,  Ichiro Uchida2 ,  Daisuke Koide3 ,  Kyoko Imamura4*
Show Less
1 Clinical Research Support Center, the University of Tokyo Hospital, Japan
2 Global Center of Medical Engineering and Informatics, Osaka University, Japan
3 Department of Clinical Epidemiology and Systems, Graduate School of Medicine, the University of Tokyo, Japan
4 Japanese Association of Pharmaceutical Medicine, Tokyo, Japan
JMDS 2019 , 4(1), 1; https://doi.org/10.18063/jmds.v2i2.166
Submitted: 9 December 2016 |
© 2019 by the Author(s). Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Download PDF
Cite
XML
HTML
Abstract

Development of new medicines has become increasingly difficult with less possibility of success in seeds-finding and ever rising operational costs. Failure to comply with ethical standards for human research protection also erodes social trust in clinical development. In order to develop competence of professionals in medicines development such as clinical investigators and drug development scientists, a variety of educational courses and training programs have been developed and executed worldwide. As Japan is no exception and shares the same concerns, significant governmental and non-governmental efforts have been made to invest in the development of academic educational courses and adherence to international standards. This article introduces examples of the adoption of technologies to realize a user-friendly and sustainable learning management as well as an adaptation of syllabuses and core curricula to meet international standards in the era of global medicines development.

Keywords
PharmaTrain
CLIC
CREDITS
JAPhMed
SMD
pharmaceutical medicine
learning management system
continuous education
References

1. PharmaTrain manual curriculum standards and best practices ver. 2.0, 2014, n.d., viewed October 15, 2016. http://www.PharmaTrain.eu/165.php
2. DiMasi J A, Grabowski H G, Hansen R W, 2016, Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47: 20–33. http://dx.doi.org/10.1016/j.jhealeco.2016.01.012
3. Nosengo N, 2016, Can you teach old drugs new tricks? Nature, 534(7607): 314–316. http://dx.doi.org/10.1038/534314a
4. Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK., n.d., viewed October 15, 2016. http://www.fpm.org.uk>
5. Dubois D J, Jurczynska A, Kerpel-Fronius S, et al. 2016, Fostering competence in medicines development: The IFAPP perspective. Frontiers in Pharmacology, 7: 377. http://dx.doi.org/10.3389/fphar.2016.00377
6. PharmaTrain mastering medicine development, n.d., viewed October 15, 2016. http://www.PharmaTrain.eu
7. Ono S, Tsutani K, Shibata T, et al. 2003, Clinical trials in Japan after implementation of the International Conference on Harmonization—Good Clinical Practice (ICH-GCP) guidelines, Pharmaceutical Development and Regulation, 1(2): 81–89. http://dx.doi.org/10.1007/BF03257368
8. Pacific Bridge Medical, 2013, Japan 5-years clinical research and trial activation plan 2012, n.d., viewed September 28, 2016. http://www.pacificbridgemedical.com/news-brief/japan-5-years-clinical-research-and-trial-activation-plan-2012/
9. University Hospital Medical Information Network Center, n.d., viewed September 28, 2016. http://www.umin.ac.jp/english/whatisumin.htm
10. Clinical Data Interchange Standard Consortium, n.d., viewed September 28 2016. http://www.cdisc.org/
11. Pharmaceuticals and Medical Devices Agency, n.d, viewed September 28, 2016. http://www.pmda.go.jp/english/index.html
12. Moodle, n.d., viewed September 28, 2016. https://moodle.org/
13. Ministry of Health, Labour and Welfare, The ethical guidelines for medical and health research involving human subjects: Provisional translation (as of March 2015). http://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdf
14. Swissethics, List of Swissethics recognized Research Ethics and GCP course providers. http://www.swissethics.ch/fortbildung_e.html
15. Koren M J, Koski G, Reed D P, et al. 2011, Statement of clinical investigator competence, APCR consensus statement. The Monitor, 25(4): 79–82.
16. European Science Foundation, 2003, A European syllabus for training clinical investigators, viewed October 24, 2016. http://www.esf.org/fileadmin/Public_documents/Publications/A_European_Syllabus_for_Training_Clinical_I-nvestigators.pdf
17. Boeynaems J M, Canivet C, Chan A, et al. 2013, A European approach to clinical investigator training. Frontiers in Pharmacology, 4: 112. http://dx.doi.org/10.3389/fphar.2013.00112
18. eCLIC: an online course for clinical investigators and their teams, n.d., viewed October 20, 2016. http://clic.bio-med.ch/cms/Default.aspx?Page=10500&Menu=103&backbar=0
19. CITI-Japan Program, Responsible conduct of research (RCR), n.d., viewed October 20, 2016. https://edu.citiprogram.jp/japan/H28_elearning_list.pdf
20. PharmaTrain specialist in medicines development (SMD) procedural document, 2014, n.d., viewed October 15, 2016. http://www.pharmatrain.eu/_downloads/Appendix_12_8_SMD_Procedural_Document_V1_0.pdf
21. Silva H, Stonier P, Buhler F, et al. 2013, Core competencies for pharmaceutical physicians and drug development scientists. Frontiers in Pharmacology, 4: 105. http://dx.doi.org/10.3389/fphar.2013.00105

Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relation ships that could be construed as a potential conflict of interest.
Next article in this issue
Share
Back to top
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept